Table 2 Hematological and clinical parameters of patients in this study
Patient information | HA group (n = 27) | DA group (n = 20) | P value |
|---|---|---|---|
Male, no. (%) | 23 (85.2) | 19 (95.0) | 0.377 |
Age (years) | 62.56 ± 1.42 | 67.75 ± 3.26 | 0.156 |
BMI (kg/m2) | 24.22 ± 0.56 | 21.59 ± 0.74 | 0.006 |
HR (bpm) | 76.10 ± 2.44 | 82.25 ± 2.27 | 0.080 |
SBP (mmHg) | 127.70 ± 2.81 | 128.50 ± 4.41 | 0.874 |
DBP (mmHg) | 73.70 ± 1.83 | 75.85 ± 2.70 | 0.499 |
Current smoker, no. (%) | 9 (33.3) | 5 (25.0) | 0.537 |
Past smoker, no. (%) | 15 (55.6) | 11 (55.0) | 0.970 |
Hypertension, no. (%) | 17 (63.0) | 11 (55.0) | 0.582 |
Diabetes, no. (%) | 10 (37.0) | 4 (20.0) | 0.347 |
CKD, no. (%) | 1 (3.7) | 3 (15.0) | 0.298 |
Past stroke, no. (%) | 2 (7.4) | 1 (5.0) | 0.613 |
Aspirin, no. (%) | 25 (92.6) | 20 (100.0) | 0.500 |
Statin, no. (%) | 25 (92.6) | 14 (70.0) | 0.100 |
ACEI/ARB, no. (%) | 12 (44.4) | 5 (25.0) | 0.170 |
Beta blockers, no. (%) | 19 (70.4) | 2 (10.0) | 0.000 |
Antiplatelet drugs, no. (%) | 23 (85.2) | 11 (55.0) | 0.056 |
Triglycerides (mM/L) | 1.37 ± 0.81 | 1.15 ± 0.83 | 0.069 |
Total cholesterol (mM/L) | 3.32 ± 0.15 | 3.62 ± 0.22 | 0.251 |
HDL cholesterol (mM/L) | 0.85 ± 0.05 | 0.96 ± 0.09 | 0.319 |
LDL cholesterol (mM/L) | 1.76 ± 0.12 | 1.83 ± 0.15 | 0.726 |
VLDL cholesterol (mM/L) | 0.63 ± 0.48 | 0.69 ± 0.06 | 0.399 |
eGFR (ml/min) | 79.09 ± 4.51 | 86.26 ± 9.48 | 0.463 |
SCr (μmol/L) | 104.37 ± 20.06 | 110.50 ± 30.47 | 0.862 |
Hemoglobin (g/L) | 127.30 ± 4.40 | 114.85 ± 5.86 | 0.090 |